|
|
|
|
01-Jun-2012
Purpose: In large stage III lung tumors, planning delivery of doses exceeding 60 Gy can be...
|
|
19-May-2012
Purpose
Non–small-cell lung cancer (NSCLC) is predominantly a disease of the elderly....
|
|
08-May-2012
Purpose
Lung cancer is the leading cause of cancer-related mortality. Intensive care unit (ICU)...
|
|
08-May-2012
Purpose
Since treatment efficacy of cisplatin- or carboplatin-based chemotherapy in the first-line...
|
|
08-May-2012
Purpose
Recent evidence has suggested a relationship between the baseline quality of life (QOL)...
|
|
02-May-2012
Objective:Our objective was to assess the usefulness of emphysema scores in predicting death from...
|
|
01-May-2012
Maintenance therapy for non-small-cell lung cancer (NSCLC) has gained acceptance in selected...
|
|
01-May-2012
The results of two clinical trials randomly allocated patients with advanced non-small-cell lung...
|
|
01-May-2012
Maintenance treatment with gefitinib significantly prolonged progression-free survival compared...
|
|
01-May-2012
Although we recorded no benefit in terms of overall survival with afatinib (which might have been...
|
|
|
|
18-May-2012
BioPharma Today
|
|
18-May-2012
BioPharma Today
|
|
18-May-2012
BioPharma Today
|
|
17-May-2012
BioPharma Today
|
|
17-May-2012
BioPharma Today
|
|
American Society of Clinical Oncology, 2003
|
|
American College of Chest Physicians (ACCP), 2007
|
|
National Comprehensive Cancer Network, 2009
|
|
American College of Chest Physicians (ACCP), 2007
|
|
European Society for Medical Oncology, 2009
|
|
